We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




HIV Relies on Host Proteins to Clear the Way to the Nucleus

By LabMedica International staff writers
Posted on 06 Jul 2016
The ability of HIV to transit the cytoplasm and enter the nucleus of an infected cell was found to depend on the combined activities of two host proteins, the Kinesin-1 motor protein, KIF5B, and the nuclear pore component Nup358.

Following envelope mediated fusion, the HIV-1 nuclear core is released into the cytoplasm of the target cell and undergoes a series of modifications that result in the nuclear import of the viral genome, which ultimately leads to the integration of viral DNA into the host cell genome. More...
Previous studies had found that disruption of microtubules, or depletion of dynein or kinesin motor proteins, perturbed the normal uncoating and trafficking of the viral genome.

In the current study, which was published in the June 21, 2016, online edition of the journal PLOS Pathogens, investigators at Loyola University (Chicago, IL, USA) enhanced the understanding of how HIV infection progresses by showing that the Kinesin-1 motor protein, KIF5B, induced a relocalization of the nuclear pore component Nup358 into the cytoplasm during HIV-1 infection. This relocalization of NUP358 was dependent on the HIV-1 capsid. NUP358 directly associated with viral cores following cytoplasmic translocation.

The interaction between NUP358 and the HIV-1 core was dependent on multiple capsid binding surfaces, as this association was not observed following infection with capsid mutants in which a conserved hydrophobic binding pocket (N74D) or the cyclophilin A binding loop (P90A) was disrupted. KIF5B knockdown also prevented the nuclear entry and infection by HIV-1, but did not exert a similar effect on the N74D or P90A capsid mutants, which do not rely on Nup358 for nuclear import.

Results obtained during these studies revealed a novel role for the microtubule motor protein KIF5B in the nuclear import of the viral genome and identified potential drug therapeutic intervention targets.

Related Links:
Loyola University



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.